LBPH News and Press, Longboard Pharmaceuticals Inc. From 01/16/24

2024-01-16 12:15:03 ET Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for LBPH on January 16, 2024 12:00PM ET. The previous analyst recommendation was Overweight. LBPH was trading at $23.99 at issue of the analyst recommendation. The overall analyst consensus...

2024-01-08 16:17:15 ET More on Longboard Pharmaceuticals Behind The Huge Rally In Longboard Pharmaceuticals Longboard Pharma: Excellent Data In Epileptic Seizures, But We Are A Little Late Now Longboard Pharmaceuticals prices upsized stock offering to raise $210 mill...

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the closing of its previously announced underwritten public offering of 11,500,000 shares of its voting commo...

2024-01-08 15:58:41 ET Summary Longboard Pharmaceuticals, Inc. shares have surged in 2024 due to positive mid-stage trial data. The company has also conducted a large capital raise through a secondary offering to fund an upcoming and pivotal Phase 3 study around its lead candidate...

2024-01-08 03:32:22 ET Summary Longboard Pharma's stock surged nearly 500% overnight on positive data for their lead candidate LP352, a therapy for neurological diseases. LP352 showed promising results in reducing seizures in patients with Developmental and Epileptic Encephalopath...

2024-01-04 08:15:14 ET Minim  ( MINM ) +145% . Omega Therapeutics  ( OMGA ) +109% signs research deals on cardiometabolic diseases. Jeffs Brands  ( JFBR ) +41% . ATIF Holdings  ( ATIF ) +20% . Arena Group Holdings ( ...

2024-01-04 01:14:07 ET More on Longboard Pharmaceuticals Longboard stock rockets 316% on positive data (update) Longboard Pharmaceuticals commences $150M public offering Seeking Alpha’s Quant Rating on Longboard Pharmaceuticals For further details see:...

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the pricing of an upsized underwritten public offering of 10,000,000 shares of its voting common stock at a p...

2024-01-03 16:34:46 ET Gainers: iHeartMedia ( IHRT ) +10% . Arcutis Biotherapeutics ( ARQT ) +8% . Cipher Mining  ( CIFR ) +7% . Pacira BioSciences ( PCRX ) +6% . Argo Blockchain  ( ARBK ) +6% . Losers: Cal-Main...

2024-01-02 17:52:42 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Polished.com Inc (AMEX: POL), C4 Therapeutics Inc. (NASDAQ: CCCC),...